Oncology

Genome-wide Interrogation of Germline Genetic Variation Associated with Treatment Response in Childhood Acute Lymphoblastic Leukemia. JAMA 2009;301:393-403.
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol doi:10.1016/S1470-2045(08)70284-5
Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal Cancer. J Clin Oncol 2009;27:176-185.
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer. NEJM 2008;359:2641-2650.
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer. J Clin Oncol 10.1200/JCO.2008.18.0786
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lance Oncol doi:10.1016/S1470-2045(08)70340-1
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia. NEJM 2009;360:659-667.
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer. NEJM 2009;360:679-691.
Colorectal Cancer Risk Prediction Tool for White Men and Women Without Known Susceptibility. J Clin Oncol 2009;27:686-693.
Management of Prostate Cancer. NEJM 2008;359:2605-2609.
Screening for Prostate Cancer among Men 75 Years of Age or Older. NEJM 2008;359:2515-2516.
Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 10.1200/JCO.2008.17.5448
Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. Lancet Oncol doi:10.1016/S1470-2045(08)70261-4
Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol 2008;26:5511-5517.
Clinical Outcome and Predictors of Survival in Late Relapse of Germ Cell Tumor. J Clin Oncol 2008;26:5524-5529.
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients. JAMA 2008;300:2277-2285.
Bevacizumab Beyond Progression: Does This Make Sense? J Clin Oncol 2008;26:5313-5315.
Prognosis, Imatinib Dose, and Benefit of Sunitinib in GIST: Knowing the Genotype. J Clin Oncol 2008;26:5322-5325.
Prognostic Variables for Resection of Colorectal Cancer Hepatic Metastases: An Evolving Paradigm. J Clin Oncol 2008;26:5320-5321.
Evidence Mounts for the Efficacy of Radioimmunotherapy for B-Cell Lymphomas. J Clin Oncol 2008;26:5147-5150.
Exploiting the Apoptotic Route for Cancer Treatment: A Single Hit Will Rarely Result in a home run. J Clin Oncol 2008;26:5151-5153.
Tyrosine Kinase Inhibitors: Can Promising New Therapy Associated With Cardiac Toxicity Strengthen the Concept of Teamwork? J Clin Oncol 2008;26:5154-5155.
Randomized Trials of Antioxidant Supplementation for Cancer Prevention. JAMA doi:10.1001/jama.2008.863
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers. JAMA doi:10.1001/jama.2008.864
Effect of Combined Folic Acid, Vitamin B₆, and Vitamin B₁₂ on Cancer Risk in Women. JAMA 2008;300:2012-2021.
The Natural History of Invasive Breast Cancers Detected by Screening Mammography. Arch Intern Med 2008;168:2311-2316.
Progress in Cancer Care:The Hope, the Hype, and the Gap Between Reality and Perception. J Clin Oncol 2008;26:5020-5021.
Breast Cancer Survivors and Hot Flashes: The Search for Nonhormonal Treatments. J Clin Oncol 2008;26:5008-5010.
Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Fading Effect? J Clin Oncol 2008;26:5014-5017.
Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group. J C lin Oncol 26;2008:4883-4890.
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials. J Clin Oncol 26;2008:4906-4911.